Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Pneumologie (Stuttgart, Germany)|January 24, 2006
[Interferon-gamma assays -- description and assessment of a new tool in the diagnosis of tuberculosis]B Hauer, R Loddenkemper, A Detjen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|December 21, 2018
Sputum smear microscopy in the Xpert® MTB/RIF eraA Van Deun, S Tahseen, D Affolabi, et al.
The European Respiratory Journal|October 5, 2010
Tuberculosis contact investigation in low prevalence countries: a European consensusC G M Erkens, M Kamphorst, I Abubakar, et al.
The New England Journal of Medicine|April 26, 2001
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance SurveillanceM A Espinal, A Laszlo, L Simonsen, et al.
The New England Journal of Medicine|June 6, 1998
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance SurveillanceA Pablos-Méndez, M C Raviglione, A Laszlo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 1, 1997
Evaluation of a standardized recording tool for sputum smear microscopy for acid-fast bacilli under routine conditions in low income countriesH L Rieder, T Arnadottir, A A Tardencilla Gutierrez, et al.
The Journal of Antimicrobial Chemotherapy|November 26, 2015
Specific gyrA gene mutations predict poor treatment outcome in MDR-TBL Rigouts, N Coeck, M Gumusboga, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 19, 2011
Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?A Trébucq, D A Enarson, C Y Chiang, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 19, 2017
Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countriesA Trébucq, V Schwoebel, Z Kashongwe, et al.
The Lancet. Infectious Diseases|January 19, 2008
Measuring tuberculosis burden, trends, and the impact of control programmesC Dye, A Bassili, A L Bierrenbach, et al.
Pageof 17